Pharmaceutical News

RSS

Among hurdles for those with opioid addictions: Getting the drug to treat it

Louis Morano knew what he needed, and he knew where to get it. He made his way to a mobile medical clinic parked on a corner of Philadelphia's Kensington neighborhood, in the geographical heart of the city's overdose crisis. People call it "the bupe bus."

16 Aug 2019

Targeted pancreatic cancer drug shows promise in clinical trials

Researchers have conducted clinical trials with a new drug targeting pancreatic cancer and the initial results are promising.

16 Aug 2019

Study finds no harm to newborns from opioid maintenance treatment during pregnancy

A new Pharmacology Research & Perspectives study found no harm to newborns from opioid maintenance treatment (OMT) during pregnancy compared with no treatment.

16 Aug 2019

MRI scans show how ADHD medication affects brain structure in children

MRI scans have revealed that children taking the medication methylphenidate experience alterations in the distribution of white matter in the brain.

15 Aug 2019

FDA approves effective new treatment for extremely drug-resistant tuberculosis

Tuberculosis is the leading infectious killer in the world, far above AIDS. It kills about 1.6 million of the 10 million it affects every year. About 30,000 patients worldwide now have XDR tuberculosis (that fails to respond to any of the four antibiotic categories in use at present).

15 Aug 2019

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.

14 Aug 2019

Effects of common anti-inflammatory drug and its degradation products on amphibians

A new study in Environmental Toxicology and Chemistry takes a harder look at the effects a common anti-inflammatory medication and its degradation products have on amphibians.

13 Aug 2019

Encapsulating two drugs in same nanovector can greatly improve drug delivery

Encapsulating two drugs with different properties into nanovesicles surrounded by antibodies can greatly improve their delivery and efficacy, according to a study led by Xavier Fernández Busquets, director of the joint Nanomalaria unit at the Institute for Bionengineering of Catalonia and the Barcelona Institute for Global Health, an institution supported by "la Caixa"

9 Aug 2019

Nonprescribed psychostimulants may boost short-term focus but impede sleep, mental functions

The use of prescription stimulants by those without medically diagnosed conditions marks a growing trend among young adults – particularly college students seeking a brain boost.

9 Aug 2019

Researchers test new drug to treat patients with chylomicronemia syndrome

People with familial chylomicronemia syndrome are born with a genetic mutation that means they can't produce an enzyme called lipoprotein lipase.

9 Aug 2019

New technique protects promising TB vaccine from heat damage

Scientists working on a new tuberculosis vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.

8 Aug 2019

Price of snakebite drug is sky high, but new competitor unlikely to lower costs

Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented its own form of misery.

8 Aug 2019

NSAIDs contribute to cardiovascular side effects in patients with osteoarthritis

Nonsteroidal anti-inflammatory drugs (NSAIDs) can help to control the pain and inflammation in individuals with osteoarthritis, but a new Arthritis & Rheumatology study suggests that NSAIDs contribute to cardiovascular side effects in these patients.

7 Aug 2019

Major step toward creation of vaccine that could neutralize ‘superbug’

Researchers from the Los Angeles Biomedical Research Institute have taken a major step toward the creation of vaccine that could neutralize the culprit behind a growing public health crisis.

6 Aug 2019

Drug used to treat alcohol use disorder reduces craving in heavy drinkers

Researchers at Yale University have identified how naltrexone, a medication used to treat alcohol use disorder, reduces craving and consumption in heavy drinkers.

6 Aug 2019

Drugmakers now ‘masters’ at rolling out their own generics to stifle competition

When PDL BioPharma's $40 million blood-pressure medicine faced the threat of a generic rival this year, the company pulled out a little-known strategy that critics say helps keep drugs expensive and competition weak.

5 Aug 2019

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.

3 Aug 2019

Probiotics for kidney disorders to be showcased at ANNA 2019 in Dallas

Kibow Biotech, Inc., Pennsylvania, will feature its product for Kidney Illness, RENADYL™, at the 50th Anniversary Meeting of the American Nephrology Nurse Association (ANNA) in Dallas, Texas, USA.

From Kibow Biotech Inc. 2 Aug 2019

Company expands development plans for drugs which slow progression to dialysis

Kibow Biotech announces that the focus on supporting and maintaining healthy kidney function with probiotics/prebiotics to potentially delay the progression to dialysis is based on its enteric toxin reduction platform technology termed "Enteric Dialysis®"

From Kibow Biotech Inc. 2 Aug 2019

New drug combination successfully reduces levels of bovine leukemia virus

Scientists have succeeded in reducing levels of the bovine leukemia virus in cows with severe infections by combining an immune checkpoint inhibitor and an enzyme inhibitor.

2 Aug 2019